top of page

Cognitact hosted the "Decoding Dementia" public health talk, focusing on cutting-edge detection tools and latest treatment breakthroughs in Alzheimer’s disease

Oct 8, 2024

On the evening of October 8, 2024, Cognitact Limited successfully hosted the free-of-entry public health talk at the Hong Kong Central Library. The seminar attracted nearly 300 attendees and received an enthusiastic response. The company was honored to have Prof. Wong Ka Sing, a specialist in neurology, and Dr. Lo See Kit, a specialist in geriatric medicine, as guest speakers. They delivered a fascinating lecture titled "Decoding Dementia - Cutting-Edge Detection Tools and Latest Treatment Breakthroughs" to the audience.


The talk revolved around the topic of Alzheimer's disease, providing detailed explanations of the disease's definition, the current challenges in diagnosis, the limitations of existing diagnostic tools, and the application prospects of innovative blood-based protein biomarker detection technology in early detection. Additionally, the specialists introduced the current drug treatment options and elaborated on the multifaceted treatment strategies and preventive measures for Alzheimer's disease.


The purpose of this talk is to promote health knowledge related to dementia and Alzheimer's disease, raising awareness of Alzheimer’s disease among the public, especially the elderly population. Cognitact hopes to take this opportunity to contribute to the promotion of healthy aging in Hong Kong society.


We would like to express our sincere gratitude to Professor Wong Ka Sing and Dr. Lo See Kit for their fascinating and eye-opening presentation, and to the Hong Kong Central Library for their tremendous support leading to the success.


As the organizer of this talk, Cognitact Limited is a biotechnology company focusing on the early detection of Alzheimer's disease. The company is committed to translating cutting-edge scientific research from one of the renowned local universities in Hong Kong into innovative early screening and diagnostic commercial tools, aiming to achieve early detection of neurodegenerative diseases through blood-based protein biomarker detection solutions.


For more information about early detection of Alzheimer's disease, please contact Cognitact Limited.

Phone: 21161678

WhatsApp: 98051678

Official website: www.cognitact.com

bottom of page